Client Login
  • About Us
  • Public Markets
    • Portfolio Managers
    • Investment Products
    • Business Partners
  • Private Markets
    • Management
    • Investment Products
  • News & Press
  • Management
  • Board of Directors
  • Contact

News & Press

Geneva Q4 2022 Review

Pier88 CEO Frank Timons presents the Geneva Q4 2022 review.

Please read our full disclosures here.

The companies identified do not represent all of the companies purchased, sold or recommended for portfolios advised by Pier 88 Investment Partners, LLC. The reader should not assume that investment in any company was or will be profitable. Additional information including a list of all companies is available upon request.

Keep Reading

Pier 88 Ventures Invests in $52mm Series B Financing for HappyCo
Pier 88 Leads $3.9 Million Series A Funding in TPN.health

Latest News

  • Investing for an M&A Cycle
  • Pier 88 Ventures Participates in Shieldpay’s Bridge Financing
  • Playing Offense & Defense Via A Convertible Bond – A Case Study
  • BlueFlag Security Emerges from Stealth with $11.5M Seed Funding to Address Critical Gaps in SDLC Security
  • Convertible Strategy: PBXIX

Latest Press

  • Pier 88 Ventures Participates in ChatLab’s $3.2M Seed Financing Round
  • Pier 88 Participates in Hammerspace Series A Funding Round
  • Pier 88 Leads $3.9 Million Series A Funding in TPN.health
  • Pier 88 Ventures Invests in $52mm Series B Financing for HappyCo
  • Pier 88 Investment Partners Expands Leadership Team

Pier 88 Investment Partners

71 Stevenson Street, Suite 825
San Francisco, CA 94105
call us: 1 (415) 814.8840email us: info@pier88.com
  • Privacy Policy
  • Cookie Policy
  • Form CRS
  • Form ADV
Copyright © 2018–2025 PIER 88 Investment Partners
Website by Creare Web Solutions

This website is not intended to provide specific investment advice or to guarantee that any past performance will be indicative of future performance results. Any reproduction or other unauthorized use is strictly prohibited. Such offers may only be made to qualified participants by means of a confidential private placement memorandum in conjunction with the limited partnership agreement and subscription agreement.